RAP
Click for more information
0.00% 20.5¢ raptor resources limited

Ann: Positive Preliminary Results from Adult Clinical Study-RAP.AX, page-220

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. epiphyte
    686 Posts.
    lightbulb Created with Sketch. 36
    clock Created with Sketch.
    21/06/16
    17:33
    Post #: 18086254
    I love this.

    "ResApp said the latest data showed the cough-based diagnostic technology demonstrated “high levels of accuracy for distinguishing adult patients with chronic obstructive pulmonary disease (96 per cent accuracy), asthma (92 per cent) or pneumonia (100 per cent) with subjects with no discernible respiratory disease”."

    Incredible.
    RAP Price at posting: 43.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
RDN Preliminary interpretation of Andover South reveals key NE-trending corridor hosting lithium mineralization
right-arrow Created with Sketch.
NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.